Continuous kidney replacement therapy in pediatric acute liver failure: What matters most—Improving biochemical parameters or improved survival?
Authors:
- 13 October 2025
- journal article
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 81 (6) , 1385-1387
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Continuous kidney replacement therapy for management of hyperammonemia and hepatic encephalopathy in pediatric acute liver failureJournal of Pediatric Gastroenterology and Nutrition, 2025
- The management of paediatric acute liver failure: results from an international multi-centre survey across EuropeIntensive Care Medicine – Paediatric and Neonatal, 2024
- Therapeutic plasma exchange provides native liver survival benefit in children with acute liver failure: A propensity score‐matched analysisJournal of Clinical Apheresis, 2024
- Pharmacokinetic profile of acyclovir in a child receiving continuous kidney replacement therapy for acute liver failurePediatric Nephrology, 2023
- Management of Poisonings and IntoxicationsClinical Journal of the American Society of Nephrology, 2023
- Therapeutic plasma exchange in children with acute liver failure (ALF): is it time for incorporation into the ALF armamentarium?Pediatric Nephrology, 2021
- Recommendation of Antimicrobial Dosing Optimization During Continuous Renal Replacement TherapyFrontiers in Pharmacology, 2020
- Effect of Continuous Renal Replacement Therapy on Outcome in Pediatric Acute Liver Failure*Critical Care Medicine, 2016